Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Respiratory Aspiration 3Neoplasms 3Neurofibromatosis 1 2Lung Neoplasms 2Postoperative Complications 1Postoperative Cognitive Complications 1Lymphoma, Follicular 1Delirium 1Carcinoma, Non-Small-Cell Lung 1Acute Lung Injury 1

Interventions

Rituximab 295Cyclophosphamide 240Peripheral Blood Stem Cell Transplantation 114fludarabine phosphate 110Filgrastim 93Etoposide 85Radiotherapy 81Lenalidomide 79Vincristine 78Prednisone 77Mycophenolic Acid 66Doxorubicin 61Cyclosporine 59Whole-Body Irradiation 58Bendamustine Hydrochloride 58Melphalan 57Tacrolimus 53Busulfan 51fludarabine 50Cytarabine 48obinutuzumab 46Methotrexate 45Antilymphocyte Serum 43Bortezomib 42Methylprednisolone 37Carmustine 37sargramostim 36ibritumomab tiuxetan 32ibrutinib 30Dexamethasone 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma, Follicular × Inhalation × Clear all
NCT07558538 2026-04-30

Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Shanghai Zhongshan Hospital

Phase EARLY_PHASE1 Not yet recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Acute Lung Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡